Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VTYX |
---|---|---|
09:32 ET | 70830 | 2.585 |
09:34 ET | 900 | 2.61 |
09:36 ET | 3024 | 2.5609 |
09:38 ET | 862 | 2.59 |
09:39 ET | 1100 | 2.585 |
09:41 ET | 555 | 2.585 |
09:43 ET | 1778 | 2.6001 |
09:45 ET | 1600 | 2.595 |
09:48 ET | 2212 | 2.6 |
09:50 ET | 11486 | 2.62 |
09:52 ET | 2732 | 2.59 |
09:54 ET | 5684 | 2.59 |
09:56 ET | 300 | 2.59 |
09:57 ET | 1100 | 2.58 |
09:59 ET | 7090 | 2.59 |
10:01 ET | 300 | 2.58 |
10:03 ET | 200 | 2.585 |
10:06 ET | 2762 | 2.56 |
10:08 ET | 1100 | 2.55 |
10:12 ET | 600 | 2.56 |
10:14 ET | 1816 | 2.56 |
10:15 ET | 16561 | 2.55 |
10:17 ET | 1518 | 2.555 |
10:19 ET | 8379 | 2.585 |
10:21 ET | 1831 | 2.59 |
10:24 ET | 670 | 2.595 |
10:26 ET | 689 | 2.61 |
10:28 ET | 4903 | 2.64 |
10:30 ET | 400 | 2.6401 |
10:32 ET | 488 | 2.6309 |
10:33 ET | 9291 | 2.6357 |
10:35 ET | 3895 | 2.6391 |
10:37 ET | 8500 | 2.6301 |
10:39 ET | 3490 | 2.62 |
10:42 ET | 2096 | 2.59 |
10:44 ET | 5400 | 2.5891 |
10:46 ET | 1476 | 2.59 |
10:48 ET | 700 | 2.6 |
10:50 ET | 200 | 2.6 |
10:51 ET | 500 | 2.6 |
10:53 ET | 2400 | 2.6 |
10:55 ET | 400 | 2.6 |
10:57 ET | 200 | 2.6 |
11:00 ET | 1009 | 2.595 |
11:02 ET | 300 | 2.595 |
11:04 ET | 1690 | 2.585 |
11:06 ET | 300 | 2.585 |
11:08 ET | 200 | 2.585 |
11:09 ET | 7524 | 2.58 |
11:11 ET | 594 | 2.5785 |
11:13 ET | 3336 | 2.61 |
11:15 ET | 300 | 2.62 |
11:18 ET | 2285 | 2.631 |
11:20 ET | 300 | 2.635 |
11:22 ET | 173 | 2.635 |
11:24 ET | 1732 | 2.635 |
11:26 ET | 3559 | 2.6209 |
11:27 ET | 500 | 2.625 |
11:29 ET | 1420 | 2.61 |
11:31 ET | 4796 | 2.615 |
11:33 ET | 500 | 2.615 |
11:36 ET | 2450 | 2.615 |
11:38 ET | 100 | 2.615 |
11:40 ET | 7841 | 2.605 |
11:44 ET | 4100 | 2.605 |
11:45 ET | 624 | 2.605 |
11:47 ET | 300 | 2.605 |
11:49 ET | 3338 | 2.61 |
11:51 ET | 4201 | 2.61 |
11:56 ET | 370 | 2.61 |
11:58 ET | 400 | 2.605 |
12:00 ET | 300 | 2.605 |
12:05 ET | 600 | 2.605 |
12:07 ET | 400 | 2.605 |
12:09 ET | 1988 | 2.6009 |
12:12 ET | 536 | 2.605 |
12:14 ET | 2589 | 2.59 |
12:16 ET | 707 | 2.5891 |
12:18 ET | 3168 | 2.59 |
12:20 ET | 2918 | 2.59 |
12:21 ET | 1800 | 2.595 |
12:23 ET | 100 | 2.59 |
12:25 ET | 200 | 2.595 |
12:27 ET | 3200 | 2.595 |
12:30 ET | 500 | 2.59 |
12:34 ET | 300 | 2.595 |
12:36 ET | 1463 | 2.58 |
12:38 ET | 800 | 2.585 |
12:39 ET | 3100 | 2.575 |
12:41 ET | 2900 | 2.575 |
12:43 ET | 300 | 2.575 |
12:45 ET | 100 | 2.58 |
12:50 ET | 2530 | 2.56 |
12:52 ET | 800 | 2.56 |
12:54 ET | 5424 | 2.575 |
12:56 ET | 2581 | 2.565 |
12:57 ET | 1000 | 2.565 |
12:59 ET | 1000 | 2.5698 |
01:01 ET | 1319 | 2.56 |
01:03 ET | 500 | 2.565 |
01:06 ET | 1200 | 2.565 |
01:08 ET | 3400 | 2.565 |
01:10 ET | 200 | 2.565 |
01:12 ET | 2184 | 2.57 |
01:14 ET | 8571 | 2.55 |
01:15 ET | 100 | 2.555 |
01:17 ET | 500 | 2.555 |
01:19 ET | 4542 | 2.56 |
01:21 ET | 300 | 2.555 |
01:24 ET | 300 | 2.555 |
01:26 ET | 1100 | 2.555 |
01:28 ET | 1024 | 2.555 |
01:32 ET | 3531 | 2.535 |
01:33 ET | 1118 | 2.54 |
01:35 ET | 12664 | 2.5499 |
01:37 ET | 19690 | 2.5521 |
01:39 ET | 490 | 2.555 |
01:42 ET | 1864 | 2.545 |
01:44 ET | 2600 | 2.545 |
01:46 ET | 1300 | 2.545 |
01:48 ET | 1212 | 2.545 |
01:50 ET | 800 | 2.56 |
01:51 ET | 300 | 2.555 |
01:53 ET | 855 | 2.5564 |
01:55 ET | 400 | 2.555 |
01:57 ET | 2551 | 2.555 |
02:00 ET | 1000 | 2.555 |
02:02 ET | 1200 | 2.5515 |
02:04 ET | 1087 | 2.555 |
02:06 ET | 936 | 2.5599 |
02:08 ET | 3896 | 2.555 |
02:09 ET | 100 | 2.555 |
02:11 ET | 1600 | 2.555 |
02:13 ET | 900 | 2.555 |
02:15 ET | 10800 | 2.555 |
02:18 ET | 1495 | 2.56 |
02:20 ET | 300 | 2.56 |
02:24 ET | 2100 | 2.56 |
02:26 ET | 14600 | 2.575 |
02:27 ET | 26229 | 2.6 |
02:29 ET | 8254 | 2.58 |
02:31 ET | 1328 | 2.58 |
02:33 ET | 748 | 2.585 |
02:36 ET | 2316 | 2.575 |
02:38 ET | 4964 | 2.545 |
02:40 ET | 14182 | 2.555 |
02:42 ET | 3119 | 2.54 |
02:44 ET | 300 | 2.545 |
02:45 ET | 6699 | 2.535 |
02:47 ET | 8081 | 2.54 |
02:49 ET | 500 | 2.5399 |
02:51 ET | 500 | 2.5399 |
02:54 ET | 344 | 2.5351 |
02:56 ET | 1048 | 2.535 |
02:58 ET | 3072 | 2.535 |
03:00 ET | 1108 | 2.55 |
03:02 ET | 6648 | 2.535 |
03:03 ET | 33349 | 2.54 |
03:05 ET | 200 | 2.545 |
03:07 ET | 200 | 2.545 |
03:09 ET | 631 | 2.545 |
03:12 ET | 5293 | 2.535 |
03:14 ET | 1727 | 2.54 |
03:16 ET | 3100 | 2.545 |
03:18 ET | 200 | 2.545 |
03:20 ET | 4927 | 2.54 |
03:21 ET | 1770 | 2.535 |
03:23 ET | 6536 | 2.525 |
03:25 ET | 1385 | 2.525 |
03:27 ET | 3389 | 2.53 |
03:30 ET | 1718 | 2.53 |
03:32 ET | 900 | 2.52 |
03:34 ET | 6709 | 2.53 |
03:36 ET | 1848 | 2.525 |
03:38 ET | 2093 | 2.525 |
03:39 ET | 9255 | 2.53 |
03:41 ET | 4226 | 2.535 |
03:43 ET | 6753 | 2.53 |
03:45 ET | 14874 | 2.525 |
03:48 ET | 1704 | 2.525 |
03:50 ET | 2701 | 2.525 |
03:52 ET | 14668 | 2.525 |
03:54 ET | 16132 | 2.5199 |
03:56 ET | 7080 | 2.515 |
03:57 ET | 20593 | 2.525 |
03:59 ET | 41270 | 2.51 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ventyx Biosciences Inc | 177.0M | -0.8x | --- |
Outlook Therapeutics Inc | 177.6M | -0.7x | --- |
Candel Therapeutics Inc | 177.9M | -4.7x | --- |
Fibrobiologics Inc | 175.0M | -4.6x | --- |
Trevi Therapeutics Inc | 185.9M | -8.0x | --- |
Biomea Fusion Inc | 186.6M | -1.5x | --- |
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $177.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.